FDA's Alzheimer's Drug Approval Deepens Searing Debate
The U.S. Food and Drug Administration's approval of the first Alzheimer's treatment in nearly two decades despite a panel's reservations cuts into a dilemma about such fast-track authorizations, pitting the needs...To view the full article, register now.
Already a subscriber? Click here to view full article